At Hilleman Laboratories, we translate early scientific discoveries into vaccines that address infectious diseases and improve global health.

• Novel vaccines and biologics for areas of high unmet medical need
• Adaptation of existing vaccines with improved delivery technologies for challenging environments in low- and middle-income countries

Hilleman Laboratories is a Singapore-based joint venture between MSD and the Wellcome Trust. Our mission is to develop affordable, high-quality vaccines through innovation, access, and strategic partnerships to advance global health.

The Scientist, Upstream Process Development is responsible for planning and executing upstream cell culture development, process optimization and technology transfer activities to support biologics and vaccine programs from early development through Phase 1/2 clinical trials.

The role applies strong scientific and hands‑on expertise in the...